SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-078685
Filing Date
2024-06-27
Accepted
2024-06-27 19:03:48
Documents
1
Period of Report
2024-06-27

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 5924
  Complete submission text file 0000950170-24-078685.txt   7377
Mailing Address 2801 CENTERVILLE ROAD 1ST FLOOR PMB #117 WILMINGTON DE 19808
Business Address 2801 CENTERVILLE ROAD 1ST FLOOR PMB #117 WILMINGTON DE 19808 877-354-3689
Eliem Therapeutics, Inc. (Issuer) CIK: 0001768446 (see all company filings)

IRS No.: 832273741 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 2525 SMITH STREET SCOTCH PLAINS NJ 07076
Business Address
Thomas Stephen Basil (Reporting) CIK: 0002027962 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40708 | Film No.: 241080891